Trailing-twelve-month (TTM) revenue is $2.98 Billion with a year-over-year growth of +7.02%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-10-31 | $751,820,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-12-17 |
| Q1 FY2026Period ended 2026-01-31 | $669,461,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-19 |
| Q2 FY2026Period ended 2026-04-30 | $740,847,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-21 |
| Q3 FY2026Period ended 2026-07-31 | $817,667,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-20 |
| TTM revenue | $2,979,795,000 |
Current P/S: $17,360,057,260 market capitalization ÷ $2,979,795,000 TTM revenue = 5.83x.
Market capitalization source: FMP quote. Quote observed 2026-09-18T20:00:01.000Z. Latest revenue period ended 2026-07-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-07-31): $817.67M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-19T00:15:50.446Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-10-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2024-10-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-10-31 · USD | FY20202020-10-31 · USD | FY20212021-10-31 · USD | FY20222022-10-31 · USD | FY20232023-10-31 · USD | FY20242024-10-31 · USD |
|---|---|---|---|---|---|---|
| Adhesive Dispensing Systems | $951M | $1.1B | $1.2B | N/A | N/A | N/A |
| Advanced Technology Systems | $986M | $978M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-10-31 · USD | FY20202020-10-31 · USD | FY20212021-10-31 · USD | FY20222022-10-31 · USD | FY20232023-10-31 · USD | FY20242024-10-31 · USD |
|---|---|---|---|---|---|---|
| Americas Excluding Us | $168M | $141M | $180M | $1.1B | $1.1B | $1.2B |
| Asia Pacific Excluding Japan | $570M | $561M | $668M |
$2.98B
$2.98 Billion
+7.02%
vs. $2.78B a year ago (TTM)
+5.12%
5 Year compound annual growth rate
1 Year
+7.02%
3 Year
+4.74%
5 Year
+5.12%
10 Year
+5.49%
15 Year
+6.30%
20 Year
+6.20%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.79B | +$101.77M | +3.78% |
| 2024 | $2.69B | +$61.29M | +2.33% |
| 2023 | $2.63B | +$38.35M | +1.48% |
| 2022 | $2.59B | +$228.07M | +9.65% |
| 2021 | $2.36B | +$241.11M | +11.37% |
| 2020 |
TTM Growth
+7.02%
3-Year CAGR
+4.74%
5-Year CAGR
+5.12%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-19T00:15:50.446Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $563M |
| $577M |
| $510M |
| Industrial Coating Systems | $257M | N/A | N/A | N/A | N/A | N/A |
|---|
| Industrial Precision Solutions | N/A | N/A | N/A | $1.3B | $1.4B | $1.5B |
|---|
| Medical And Fluid Solutions | N/A | N/A | N/A | $690M | $660M | $695M |
|---|
| $796M |
| $785M |
| Europe | $572M | $537M | $617M | $646M | $683M | $726M |
|---|
| JAPAN | $127M | $127M | $108M | N/A | N/A | N/A |
|---|
| UNITED STATES | $758M | $756M | $789M | N/A | N/A | N/A |
|---|
| $2.12B |
| ($73.13M) |
| (3.33%) |
| 2019 | $2.19B | ($60.44M) | (2.68%) |
| 2018 | $2.25B | +$187.69M | +9.08% |
| 2017 | $2.07B | +$257.99M | +14.26% |
| 2016 | $1.81B | +$120.33M | +7.13% |
